Study guide

6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring

Veterinary Technician Specialist in Emergency and Critical Care VTS ECC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment

1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions

2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR

2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance

3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders

4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation

4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics

5 Chapter 5: Gastrointestinal & Hepatic Emergencies

5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies

6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions

6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions

7 Chapter 7: Renal & Urinary Emergencies

7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation

8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS

8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia

9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies

9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles

10 Chapter 10: Neurological Emergencies

10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization

11 Chapter 11: Endocrine & Metabolic Crises

11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

12 Chapter 12: Reproductive & Musculoskeletal Emergencies

12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20

13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist

6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring

Key Takeaways Explain This Topic AI

Constant Rate Infusions (CRIs) provide continuous, stable plasma drug concentrations at steady state (Css), eliminating peaks (which trigger cardiovascular/respiratory side effects) and troughs (which cause breakthrough pain).

Administering an intravenous loading dose (bolus) prior to initiating a CRI is mandatory; omitting a loading dose delays reaching steady-state therapeutic plasma concentrations by 3 to 5 elimination half-lives (t1/2).

Syringe pumps delivering dedicated, unadulterated drug solutions represent the clinical gold standard in ECC, preventing accidental drug overdoses when primary IV fluid rates are altered during shock resuscitation.

Systemic multi-modal emergency CRIs (MLK and FLK) combine mu-opioids, lidocaine, and ketamine for broad nociceptive coverage in dogs, but systemic Lidocaine CRIs are strictly avoided or dose-restricted in cats due to fatal feline cardiotoxicity and methemoglobinemia.

Precision in CRI mathematics requires mastering both syringe pump delivery rates (mL/hr) and fluid bag addition formulas, utilizing rigorous dimensional analysis and unit conversions (mcg to mg, min to hr).

Last updated: August 2026

Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring

VTS Core Concept: Intermittent 'as-needed' (PRN) intravenous boluses create a volatile 'peak-and-valley' pharmacokinetic profile. Peak drug concentrations frequently induce unwanted side effects (hypotension, respiratory depression, bradycardia, dysphoria), while trough concentrations plunge below the minimum effective concentration (MEC), causing agonizing breakthrough pain. Constant Rate Infusions (CRIs) maintain stable steady-state plasma concentrations (Css), lower the total 24-hour drug requirement by 20-40%, and allow minute-by-minute titration to patient needs.

1. Pharmacokinetics of CRIs & The Loading Dose Rule

When a drug is infused at a constant rate (R), the time required to reach steady-state plasma concentration (Css) depends exclusively on the drug's elimination half-life (t1/2) , governed by the formula:

  • Css = Infusion Rate (R) / Systemic Clearance (Cl)
  • The Loading Dose Rule

Without a loading dose, it takes 3.3 half-lives to reach 90% of steady state, and 5 half-lives to reach 97% of steady state.

For drugs with long half-lives or patients in acute severe pain, waiting 3-5 half-lives means hours of untreated suffering or hemodynamic instability.

Mandatory Clinical Practice: Always administer an intravenous loading dose (bolus) immediately prior to starting the CRI to instantaneously elevate plasma concentration into the therapeutic window, which the CRI then maintains. [ Intermittent Bolus ] ==> Peaks (Toxicity/Sedation) + Valleys (Breakthrough Pain)

  • [ CRI Without Bolus ] ==> Steady rise taking 3 to 5 elimination half-lives to reach therapeutic MEC
  • [ Bolus + CRI ] ==> Instantaneous therapeutic MEC sustained continuously at steady state (Css)
  • 2. Common Emergency and Critical Care CRIs

CRI Agent / Protocol Receptor / Mechanism Target Species IV Loading Dose CRI Maintenance Dose Range Primary Clinical ECC Indications & Safety Warnings

Fentanyl Pure mu-opioid receptor agonist Dogs & Cats 2-5 mcg/kg IV slow 2-5 mcg/kg/hr (titrated up to 10 mcg/kg/hr for severe trauma) Severe acute pain (pancreatitis, trauma, peritonitis, post-op celiotomy). Rapid onset, short t1/2 (45 min). Monitor for dose-dependent respiratory depression and bradycardia

Ketamine Non-competitive NMDA receptor antagonist Dogs & Cats 0.2-0.5 mg/kg IV 2-10 mcg/kg/min (0.12-0.6 mg/kg/hr) Subanesthetic analgesia, prevents and reverses central sensitization ('wind-up'), opioid-sparing. Does not cause dissociative emergence at these micro-doses

Lidocaine Voltage-gated Na+ channel blocker; Class Ib DOGS ONLY 1-2 mg/kg IV slow 25-50 mcg/kg/min (1.5-3.0 mg/kg/hr) Visceral analgesia, ventricular antiarrhythmic (VPCs/V-tach), GI prokinetic, free radical scavenger in GDV/ischemia-reperfusion. CONTRAINDICATED / AVOID IN CATS

Dexmedetomidine Central alpha-2-adrenergic agonist Dogs & Cats 0.5-1.0 mcg/kg IV 0.5-2.0 mcg/kg/hr Adjunctive multimodal analgesia, ICU sedation, emergence delirium, severe anxiety in mechanical ventilation. Monitor for peripheral vasoconstriction and bradycardia

MLK (Morphine-Lidocaine-Ketamine) mu-Opioid + Na+ channel blocker + NMDA antagonist DOGS ONLY Species-specific boluses M: 0.12 mg/kg/hr; L: 1.8-3.0 mg/kg/hr; K: 0.12-0.6 mg/kg/hr Premier triple-combination multimodal analgesic infusion for severe canine surgical trauma, amputations, and septic peritonitis. Synergistic analgesia targeting 3 distinct pain pathways

FLK (Fentanyl-Lidocaine-Ketamine) Pure mu-Opioid + Na+ blocker + NMDA antagonist DOGS ONLY Species-specific boluses F: 2-5 mcg/kg/hr; L: 1.8-3.0 mg/kg/hr; K: 0.12-0.6 mg/kg/hr Alternative to MLK when fentanyl is preferred over morphine (e.g., acute surgical cases requiring faster onset and rapid titratability)

Critical Feline Species Alert: Lidocaine Toxicity

Feline hepatic metabolism possesses a deficiency in glucuronyl transferase and slow cytochrome P450 biotransformation pathways. Systemic intravenous infusions of Lidocaine in cats cause severe central nervous system toxicity (seizures, muscle tremors, coma) , methemoglobinemia , and profound negative inotropy and cardiovascular collapse at doses that are routine in dogs. Systemic Lidocaine CRIs should be avoided in cats; use Fentanyl-Ketamine (FK) or Morphine-Ketamine (MK) instead.

Loading diagram... CRI Delivery Method Decision Tree and Patient Safety Rules

3. Step-by-Step CRI Mathematical Formulas

Veterinary technicians must achieve absolute fluency in both syringe pump and fluid bag additive calculations.

Method 1: Syringe Pump Calculation (Dedicated Infusion)

Syringe pumps deliver undiluted (or lightly diluted) drug solution at a precise volumetric rate in mL/hr:

Infusion Rate (mL/hr) = (Dose [mg/kg/hr or mcg/kg/hr] x Body Weight [kg]) / Drug Stock Concentration [mg/mL or mcg/mL]

Unit Conversion Rule: If the target dose is prescribed in mcg/kg/min, first convert to mcg/kg/hr by multiplying by 60 min/hr: Dose (mcg/kg/hr) = Dose (mcg/kg/min) x 60

Method 2: Adding Medication to an IV Fluid Bag

When compounding a CRI directly into a maintenance fluid bag, the concentration of the drug within the bag must be tailored to the patient's specific fluid administration rate (mL/hr):

mg of Drug to Add = (Dose [mcg/kg/min] x Body Weight [kg] x Bag Volume [mL] x 60 min/hr) / (Fluid Infusion Rate [mL/hr] x 1000 mcg/mg)

For a dose prescribed in mg/kg/hr: mg of Drug to Add = (Dose [mg/kg/hr] x Body Weight [kg] x Bag Volume [mL]) / Fluid Infusion Rate [mL/hr]

Once the total milligrams (mg) are calculated, determine the volume (mL) of stock solution to draw: Volume of Drug to Add (mL) = mg of Drug to Add / Drug Stock Concentration (mg/mL)

  • 4. Worked Clinical Calculation Examples
  • Worked Example 1: Syringe Pump Fentanyl CRI

Patient: 20 kg dog presenting with severe acute pancreatitis.

Order: Fentanyl CRI at 4 mcg/kg/hr via syringe pump. Stock concentration is 50 mcg/mL (0.05 mg/mL).

  • Step 1: Calculate hourly dose in mcg/hr: 4 mcg/kg/hr x 20 kg = 80 mcg/hr
  • Step 2: Calculate syringe pump infusion rate in mL/hr: Rate = 80 mcg/hr / 50 mcg/mL = 1.6 mL/hr

Clinical Action: Program the syringe pump to run at 1.6 mL/hr .

Worked Example 2: Syringe Pump Ketamine CRI (Unit Conversion)

Patient: 4.0 kg cat post-femoral fracture repair.

Order: Ketamine CRI at 5 mcg/kg/min via syringe pump. Stock concentration is 100 mg/mL.

  • Step 1: Convert dose from mcg/kg/min to mg/kg/hr: 5 mcg/kg/min x 60 min/hr = 300 mcg/kg/hr = 0.3 mg/kg/hr
  • Step 2: Calculate total hourly dose in mg/hr: 0.3 mg/kg/hr x 4.0 kg = 1.2 mg/hr

Step 3: Calculate syringe pump rate (stock 100 mg/mL): Rate = 1.2 mg/hr / 100 mg/mL = 0.012 mL/hr (Note: Because 0.012 mL/hr is too small for standard pumps, dilute 1.0 mL of 100 mg/mL ketamine into 9.0 mL of sterile saline to make a 10 mg/mL solution. New pump rate = 1.2 mg/hr / 10 mg/mL = 0.12 mL/hr).

Worked Example 3: Compounding Ketamine into an IV Fluid Bag

Patient: 25 kg dog with septic peritonitis.

Order: Add Ketamine to a 1,000 mL bag of Normosol-R to deliver 10 mcg/kg/min while the IV fluids run at a maintenance rate of 75 mL/hr. Ketamine stock concentration is 100 mg/mL.

Step 1: Apply fluid bag additive formula: mg to Add = (10 mcg/kg/min x 25 kg x 1,000 mL x 60 min/hr) / (75 mL/hr x 1,000 mcg/mg) = 15,000,000 / 75,000 = 200 mg of Ketamine

Step 2: Calculate volume of stock ketamine to add: Volume = 200 mg / 100 mg/mL = 2.0 mL

Step 3: Nursing Action: Remove 2.0 mL of Normosol-R from the 1,000 mL bag, inject 2.0 mL (200 mg) of stock ketamine, mix thoroughly, label clearly, and run at 75 mL/hr.

5. Clinical Safety, Dedicated Lines & Quality Control

The Dedication Principle: Syringe pump CRIs should ideally run through a dedicated IV line or dedicated lumen of a multi-lumen central venous catheter (CVC) . If piggybacked into a carrier line, an anti-reflux one-way check valve must be installed on the carrier line to prevent drug backflow into the primary fluid bag.

The Fluid Rate Trap: If a CRI is mixed into an IV fluid bag, any change in the fluid pump rate directly changes the drug dose . If the patient develops hypotension and the technician administers a 500 mL fluid bolus from that bag, the patient will receive a massive, potentially fatal overdose of the compounded drug!

CRI Labeling Standards: Every CRI bag or syringe must have a bright auxiliary label detailing: Patient Name and Weight, Drug(s) Added and Exact Amount (mg or mcg), Final Concentration, Date and Time Prepared, Infusion Rate Range, and Initials of the Compounding Technician.

Light Sensitivity: Certain drugs (e.g., Sodium Nitroprusside, Dexmedetomidine) are photodegradable and require light-protective opaque sleeves or amber syringe casings.